Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU

Brian Orelli, PhD, The Motley Fool
·2 min read
Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU

Score another pre-approval sale for coronavirus vaccine-maker Moderna (NASDAQ: MRNA). European Commission President Ursula von der Leyen has announced that the EC will ink a deal with the company on Wednesday. The contract will allow the European Union's member countries to purchase up to 160 million doses of Moderna's COVID-19 vaccine, mRNA-1273, once the vaccine is approved by EU regulators.